Business Summary
Becton, Dickinson and Company (BD) is a global medical technology company incorporated in New Jersey in 1897, engaged in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. BD serves healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry, and the general public across more than 190 countries. As of fiscal year 2025 (ended September 30, 2025), BD employed approximately 72,000 associates in 61 countries.
BD operated three business segments during FY2025: BD Medical, BD Life Sciences, and BD Interventional. Effective October 1, 2025, BD reorganized into five segments: Medical Essentials, Connected Care, BioPharma Systems, Interventional, and Life Sciences. A transformative strategic event in FY2025 was the July 2025 announcement of a Reverse Morris Trust transaction to combine BD's Biosciences and Diagnostic Solutions businesses with Waters Corporation, with BD expected to receive approximately $4 billion cash and BD shareholders to...
AI-generated summary of Item 1 (Business) from the 10-K filed Nov 25, 2025 — View filing on SEC.gov. May contain errors — refer to the filing for authoritative information.
Across SEC filings
Institutional holders · 13F
Q2 2026| Largest holders | Reported value |
|---|---|
| BlackRock Inc | $3.7B |
| VANGUARD CAPITAL MANAGEMENT LLC | $2.7B |
| MASSACHUSETTS FINANCIAL SERVICES CO MA | $2.5B |
| STATE STREET CORPORATION | $2.3B |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.3B |
Annual results · 10-K
Fiscal 2025- Revenue
- $21.8B
- Net income
- $1.7B
As reported in the fiscal 2025 annual report.
Funds & ETFs · N-PORT
Securities
Insider trades · Form 4
Latest filings
- Michael Feld 2026-10-27 Sell
- Michael Feld 2026-09-30 Sell
- Vitor Roque 2026-09-03 -
- Michael Feld 2026-08-27 Sell
- Michael Feld 2026-08-24 -
5%+ holders · 13D/G
4 filers| Filer | % of class | Filed |
|---|---|---|
| STATE STREET CORPORATION 13G | 5.4% | 2026-08-07 |
| First Eagle Investment Management LLC 13G | 5.1% | 2026-08-06 |
| VANGUARD CAPITAL MANAGEMENT LLC 13G | 7.5% | 2026-04-29 |
| VANGUARD PORTFOLIO MANAGEMENT LLC 13G | 5.4% | 2026-04-29 |
Latest Schedule 13D or 13G from each filer; stakes a filer has reported closed are left out.